Tapewire

Nasdaq · USD

RXRX

RECURSION PHARMACEUTICALS, INC.

Export transactions ↓
Tapewire entity
1008
SEC CIK
0001601830
Parsed reports
506

Last 12 months

Inside the activity.

0 purchase rows · 35 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202502
Dec 202505
Jan 202603
Feb 202604
Mar 202604
Apr 202603
May 202603
Jun 202605
Jul 202601
Aug 202601
Sep 202602
Oct 202602

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
April 03, 2023 Filed Apr 5, 2023 22:00 UTC
Li Dean YDirector
GrantClass A Common Stock 1,724 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-023433 · doc4.xml · nonDerivative · entry 1

Li Dean Y · CIK 0001837016 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 623,409

F1 · shares: The shares were issued pursuant to the Issuer's Outside Director Compensation Policy.

Read SEC document
April 03, 2023 Filed Apr 28, 2023 20:34 UTC Amendment
Dar ZavainDirector
GrantClass A Common Stock 1,996 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-026049 · doc4a.xml · nonDerivative · entry 1

Dar Zavain · CIK 0001852075 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 57,569

F1 · shares: The shares were issued pursuant to the Issuer's Outside Director Compensation Policy.

F2 · balance_after: Includes a total of 35,008 shares received pursuant to a pro-rata distribution from Lux Ventures, of which the Reporting Person was a limited partner. The acquisition of such shares was exempt pursuant to Rule 16a-9 and was inadvertently excluded from the total amount of shares held on the original Form 4 filing.

Read SEC document
March 21, 2023 Filed Mar 23, 2023 21:07 UTC SaleClass A Common Stock 8,885 $7.40 $65,743.67
Disclosure

SEC source: 0001209191-23-020799 · doc4.xml · nonDerivative · entry 1

Borgeson Blake · CIK 0001856094 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,576,287

F1 · kind: Sales are pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 9, 2022.

F2 · price: The sales price reported herein is a weighted average price. These shares were sold in multiple lots at prices ranging from $7.27 to $7.49 per share. Full sale price information for each lot is available to the Issuer's stockholders and the staff of the U.S. Securities and Exchange Commission upon their written request.

Read SEC document
March 13, 2023 Filed Mar 15, 2023 23:03 UTC
Gibson ChristopherDirector · Chief Executive Officer
ConversionClass B Common Stock · Derivative 3,000 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001209191-23-019041 · doc4.xml · derivative · entry 7

Gibson Christopher · CIK 0001856369 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,618,834

Underlying: Class A Common Stock · 3,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F2 · kind: Represents the conversion of Class B Common Stock into Class A Common Stock.

F6 · derivative.exercise_date: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.

F6 · derivative.expiration_date: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.

Read SEC document
March 13, 2023 Filed Mar 15, 2023 23:03 UTC
Gibson ChristopherDirector · Chief Executive Officer
GiftClass A Common Stock 3,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-019041 · doc4.xml · nonDerivative · entry 2

Gibson Christopher · CIK 0001856369 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 938,787

F1 · kind: Transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

Read SEC document
March 13, 2023 Filed Mar 15, 2023 23:03 UTC
Gibson ChristopherDirector · Chief Executive Officer
ConversionClass A Common Stock 3,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-019041 · doc4.xml · nonDerivative · entry 1

Gibson Christopher · CIK 0001856369 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 941,787

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F2 · kind: Represents the conversion of Class B Common Stock into Class A Common Stock.

Read SEC document
March 09, 2023 Filed Mar 10, 2023 22:34 UTC
Gibson ChristopherDirector · Chief Executive Officer
SaleClass A Common Stock 15,000 $7.77 $116,620.50
Disclosure

SEC source: 0001209191-23-017918 · doc4.xml · nonDerivative · entry 10

Gibson Christopher · CIK 0001856369 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 938,787

F1 · kind: Transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F10 · price: This transaction was executed in multiple trades at prices ranging from $7.46 to $8.19. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

Read SEC document
March 08, 2023 Filed Mar 10, 2023 22:34 UTC
Gibson ChristopherDirector · Chief Executive Officer
ConversionClass B Common Stock · Derivative 1,000 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001209191-23-017918 · doc4.xml · derivative · entry 18

Gibson Christopher · CIK 0001856369 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · by Gibson Family Trust

Disclosed balance after: 123,875

Underlying: Class A Common Stock · 1,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F3 · kind: Represents the conversion of Class B Common Stock into Class A Common Stock.

F14 · derivative.exercise_date: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.

F14 · derivative.expiration_date: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.

F8 · ownership.nature: The shares are held by the Gibson Family Trust, of which the Reporting Person serves as Trustee.

Read SEC document
March 08, 2023 Filed Mar 10, 2023 22:34 UTC
Gibson ChristopherDirector · Chief Executive Officer
ConversionClass B Common Stock · Derivative 20,000 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001209191-23-017918 · doc4.xml · derivative · entry 17

Gibson Christopher · CIK 0001856369 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · by LAHWRAN-4 LLC

Disclosed balance after: 508,000

Underlying: Class A Common Stock · 20,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F3 · kind: Represents the conversion of Class B Common Stock into Class A Common Stock.

F14 · derivative.exercise_date: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.

F14 · derivative.expiration_date: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.

F6 · ownership.nature: The shares are held by LAHWRAN-4 LLC, of which the Reporting Person is a member and a manager.

Read SEC document
March 08, 2023 Filed Mar 10, 2023 22:34 UTC
Gibson ChristopherDirector · Chief Executive Officer
ConversionClass B Common Stock · Derivative 4,000 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001209191-23-017918 · doc4.xml · derivative · entry 16

Gibson Christopher · CIK 0001856369 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · by LAHWRAN-3 LLC

Disclosed balance after: 535,000

Underlying: Class A Common Stock · 4,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F3 · kind: Represents the conversion of Class B Common Stock into Class A Common Stock.

F14 · derivative.exercise_date: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.

F14 · derivative.expiration_date: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.

F4 · ownership.nature: The shares are held by LAHWRAN-3 LLC, of which the Reporting Person is a member and a manager.

Read SEC document
March 08, 2023 Filed Mar 10, 2023 22:34 UTC
Gibson ChristopherDirector · Chief Executive Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 93,750 $0.00 Strike: $2.48 $0.00
Disclosure

SEC source: 0001209191-23-017918 · doc4.xml · derivative · entry 14

Gibson Christopher · CIK 0001856369 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 687,500

Underlying: Class A Common Stock · 93,750 shares

Expires 2030-12-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F13 · derivative.exercise_date: The option, originally for 1,500,000 shares, vested as to one forty-eighth (1/48th) of the shares subject to the option on January 31, 2021, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter.

Read SEC document
March 08, 2023 Filed Mar 10, 2023 22:34 UTC
Gibson ChristopherDirector · Chief Executive Officer
SaleClass A Common Stock 1,000 $8.09 $8,086.70
Disclosure

SEC source: 0001209191-23-017918 · doc4.xml · nonDerivative · entry 9

Gibson Christopher · CIK 0001856369 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · by Gibson Family Trust

Disclosed balance after: 0

F1 · kind: Transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F9 · price: This transaction was executed in multiple trades at prices ranging from $8.03 to $8.28. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F8 · ownership.nature: The shares are held by the Gibson Family Trust, of which the Reporting Person serves as Trustee.

Read SEC document
March 08, 2023 Filed Mar 10, 2023 22:34 UTC
Gibson ChristopherDirector · Chief Executive Officer
ConversionClass A Common Stock 1,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-017918 · doc4.xml · nonDerivative · entry 8

Gibson Christopher · CIK 0001856369 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · by Gibson Family Trust

Disclosed balance after: 1,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F3 · kind: Represents the conversion of Class B Common Stock into Class A Common Stock.

F8 · ownership.nature: The shares are held by the Gibson Family Trust, of which the Reporting Person serves as Trustee.

Read SEC document
March 08, 2023 Filed Mar 10, 2023 22:34 UTC
Gibson ChristopherDirector · Chief Executive Officer
SaleClass A Common Stock 20,000 $8.10 $161,900.00
Disclosure

SEC source: 0001209191-23-017918 · doc4.xml · nonDerivative · entry 7

Gibson Christopher · CIK 0001856369 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · by LAHWRAN-4 LLC

Disclosed balance after: 0

F1 · kind: Transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F7 · price: This transaction was executed in multiple trades at prices ranging from $7.98 to $8.16. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F6 · ownership.nature: The shares are held by LAHWRAN-4 LLC, of which the Reporting Person is a member and a manager.

Read SEC document
March 08, 2023 Filed Mar 10, 2023 22:34 UTC
Gibson ChristopherDirector · Chief Executive Officer
ConversionClass A Common Stock 20,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-017918 · doc4.xml · nonDerivative · entry 6

Gibson Christopher · CIK 0001856369 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · by LAHWRAN-4 LLC

Disclosed balance after: 20,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F3 · kind: Represents the conversion of Class B Common Stock into Class A Common Stock.

F6 · ownership.nature: The shares are held by LAHWRAN-4 LLC, of which the Reporting Person is a member and a manager.

Read SEC document
March 08, 2023 Filed Mar 10, 2023 22:34 UTC
Gibson ChristopherDirector · Chief Executive Officer
SaleClass A Common Stock 4,000 $8.09 $32,361.60
Disclosure

SEC source: 0001209191-23-017918 · doc4.xml · nonDerivative · entry 5

Gibson Christopher · CIK 0001856369 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · by LAHWRAN-3 LLC

Disclosed balance after: 0

F1 · kind: Transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F5 · price: This transaction was executed in multiple trades at prices ranging from $8.02 to $8.15. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F4 · ownership.nature: The shares are held by LAHWRAN-3 LLC, of which the Reporting Person is a member and a manager.

Read SEC document
March 08, 2023 Filed Mar 10, 2023 22:34 UTC
Gibson ChristopherDirector · Chief Executive Officer
ConversionClass A Common Stock 4,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-017918 · doc4.xml · nonDerivative · entry 4

Gibson Christopher · CIK 0001856369 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · by LAHWRAN-3 LLC

Disclosed balance after: 4,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F3 · kind: Represents the conversion of Class B Common Stock into Class A Common Stock.

F4 · ownership.nature: The shares are held by LAHWRAN-3 LLC, of which the Reporting Person is a member and a manager.

Read SEC document
March 08, 2023 Filed Mar 10, 2023 22:34 UTC
Gibson ChristopherDirector · Chief Executive Officer
GiftClass A Common Stock 10,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-017918 · doc4.xml · nonDerivative · entry 3

Gibson Christopher · CIK 0001856369 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 953,787

F1 · kind: Transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

Read SEC document
March 08, 2023 Filed Mar 10, 2023 22:34 UTC
Gibson ChristopherDirector · Chief Executive Officer
SaleClass A Common Stock 70,890 $8.10 $573,925.44
Disclosure

SEC source: 0001209191-23-017918 · doc4.xml · nonDerivative · entry 2

Gibson Christopher · CIK 0001856369 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 963,787

F1 · kind: Transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F2 · price: This transaction was executed in multiple trades at prices ranging from $7.98 to $8.16. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

Read SEC document
March 08, 2023 Filed Mar 10, 2023 22:34 UTC
Gibson ChristopherDirector · Chief Executive Officer
Exercise / conversionClass A Common Stock 93,750 $2.48 $232,500.00
Disclosure

SEC source: 0001209191-23-017918 · doc4.xml · nonDerivative · entry 1

Gibson Christopher · CIK 0001856369 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,034,677

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

Read SEC document
March 07, 2023 Filed Mar 9, 2023 22:36 UTC SaleClass A Common Stock 8,885 $8.33 $73,988.95
Disclosure

SEC source: 0001209191-23-017619 · doc4.xml · nonDerivative · entry 1

Borgeson Blake · CIK 0001856094 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,585,172

F1 · kind: Sales are pursuant to a 10b5-1 trading plan established by the Reporting Person.

F2 · price: The sales price reported herein is a weighted average price. These shares were sold in multiple lots at prices ranging from $8.10 to $8.49 per share. Full sale price information for each lot is available to the Issuer's stockholders and the staff of the U.S. Securities and Exchange Commission upon their written request.

Read SEC document
March 02, 2023 Filed Mar 3, 2023 16:09 UTC PurchaseClass A Common Stock 66,822 $7.82 $522,354.26
Disclosure

SEC source: 0001839882-23-005947 · rxrx-form4_030223.xml · nonDerivative · entry 1

Mubadala Investment Co PJSC · CIK 0001704268 · 10% owner

Mamoura Diversified Global Holding PJSC · CIK 0001419351 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Explanation of Responses

Disclosed balance after: 12,985,927

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.71 to $7.97, inclusive. The reporting person undertakes to provide to Recursion Pharmaceuticals, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this Form 4.

F2 · ownership.nature: Consists of 12,985,927 shares held of record by Fifteenth Investment Company LLC. Fifteenth Investment Company LLC is a wholly owned subsidiary of Mamoura Diversified Global Holdings PJSC, which is wholly owned by Mubadala Investment Company PJSC, which is wholly owned by the Government of Abu Dhabi.

F4 · ownership.nature: Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any.

F5 · ownership.nature: Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests.

Read SEC document
March 02, 2023 Filed Mar 6, 2023 23:07 UTC
Gibson ChristopherDirector · Chief Executive Officer
ConversionClass B Common Stock · Derivative 1,000 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001209191-23-016450 · doc4.xml · derivative · entry 16

Gibson Christopher · CIK 0001856369 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · by Gibson Family Trust

Disclosed balance after: 124,875

Underlying: Class A Common Stock · 1,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F2 · kind: Represents the conversion of Class B Common Stock into Class A Common Stock.

F13 · derivative.exercise_date: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.

F13 · derivative.expiration_date: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.

F8 · ownership.nature: The shares are held by the Gibson Family Trust, of which the Reporting Person serves as Trustee.

Read SEC document
March 02, 2023 Filed Mar 6, 2023 23:07 UTC
Gibson ChristopherDirector · Chief Executive Officer
ConversionClass B Common Stock · Derivative 1,000 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001209191-23-016450 · doc4.xml · derivative · entry 15

Gibson Christopher · CIK 0001856369 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · by LAHWRAN-4 LLC

Disclosed balance after: 528,000

Underlying: Class A Common Stock · 1,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F2 · kind: Represents the conversion of Class B Common Stock into Class A Common Stock.

F13 · derivative.exercise_date: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.

F13 · derivative.expiration_date: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.

F6 · ownership.nature: The shares are held by LAHWRAN-4 LLC, of which the Reporting Person is a member and a manager.

Read SEC document
March 02, 2023 Filed Mar 6, 2023 23:07 UTC
Gibson ChristopherDirector · Chief Executive Officer
ConversionClass B Common Stock · Derivative 500 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001209191-23-016450 · doc4.xml · derivative · entry 14

Gibson Christopher · CIK 0001856369 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · by LAHWRAN-3 LLC

Disclosed balance after: 539,000

Underlying: Class A Common Stock · 500 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F2 · kind: Represents the conversion of Class B Common Stock into Class A Common Stock.

F13 · derivative.exercise_date: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.

F13 · derivative.expiration_date: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.

F4 · ownership.nature: The shares are held by LAHWRAN-3 LLC, of which the Reporting Person is a member and a manager.

Read SEC document
March 02, 2023 Filed Mar 6, 2023 23:07 UTC
Gibson ChristopherDirector · Chief Executive Officer
ConversionClass B Common Stock · Derivative 18,500 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001209191-23-016450 · doc4.xml · derivative · entry 13

Gibson Christopher · CIK 0001856369 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,621,834

Underlying: Class A Common Stock · 18,500 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F2 · kind: Represents the conversion of Class B Common Stock into Class A Common Stock.

F13 · derivative.exercise_date: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.

F13 · derivative.expiration_date: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.

Read SEC document
March 02, 2023 Filed Mar 6, 2023 23:07 UTC
Gibson ChristopherDirector · Chief Executive Officer
SaleClass A Common Stock 1,000 $7.91 $7,908.60
Disclosure

SEC source: 0001209191-23-016450 · doc4.xml · nonDerivative · entry 8

Gibson Christopher · CIK 0001856369 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · by Gibson Family Trust

Disclosed balance after: 0

F1 · kind: Transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F9 · price: This transaction was executed in multiple trades at prices ranging from $7.75 to $8.05. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F8 · ownership.nature: The shares are held by the Gibson Family Trust, of which the Reporting Person serves as Trustee.

Read SEC document
March 02, 2023 Filed Mar 6, 2023 23:07 UTC
Gibson ChristopherDirector · Chief Executive Officer
ConversionClass A Common Stock 1,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-016450 · doc4.xml · nonDerivative · entry 7

Gibson Christopher · CIK 0001856369 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · by Gibson Family Trust

Disclosed balance after: 1,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F2 · kind: Represents the conversion of Class B Common Stock into Class A Common Stock.

F8 · ownership.nature: The shares are held by the Gibson Family Trust, of which the Reporting Person serves as Trustee.

Read SEC document
March 02, 2023 Filed Mar 6, 2023 23:07 UTC
Gibson ChristopherDirector · Chief Executive Officer
SaleClass A Common Stock 1,000 $7.91 $7,905.90
Disclosure

SEC source: 0001209191-23-016450 · doc4.xml · nonDerivative · entry 6

Gibson Christopher · CIK 0001856369 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · by LAHWRAN-4 LLC

Disclosed balance after: 0

F1 · kind: Transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F7 · price: This transaction was executed in multiple trades at prices ranging from $7.74 to $8.05. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F6 · ownership.nature: The shares are held by LAHWRAN-4 LLC, of which the Reporting Person is a member and a manager.

Read SEC document
March 02, 2023 Filed Mar 6, 2023 23:07 UTC
Gibson ChristopherDirector · Chief Executive Officer
ConversionClass A Common Stock 1,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-016450 · doc4.xml · nonDerivative · entry 5

Gibson Christopher · CIK 0001856369 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · by LAHWRAN-4 LLC

Disclosed balance after: 1,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F2 · kind: Represents the conversion of Class B Common Stock into Class A Common Stock.

F6 · ownership.nature: The shares are held by LAHWRAN-4 LLC, of which the Reporting Person is a member and a manager.

Read SEC document
March 02, 2023 Filed Mar 6, 2023 23:07 UTC
Gibson ChristopherDirector · Chief Executive Officer
SaleClass A Common Stock 500 $7.90 $3,952.05
Disclosure

SEC source: 0001209191-23-016450 · doc4.xml · nonDerivative · entry 4

Gibson Christopher · CIK 0001856369 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · by LAHWRAN-3 LLC

Disclosed balance after: 0

F1 · kind: Transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F5 · price: This transaction was executed in multiple trades at prices ranging from $7.73 to $8.05. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F4 · ownership.nature: The shares are held by LAHWRAN-3 LLC, of which the Reporting Person is a member and a manager.

Read SEC document
March 02, 2023 Filed Mar 6, 2023 23:07 UTC
Gibson ChristopherDirector · Chief Executive Officer
ConversionClass A Common Stock 500 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-016450 · doc4.xml · nonDerivative · entry 3

Gibson Christopher · CIK 0001856369 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · by LAHWRAN-3 LLC

Disclosed balance after: 500

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F2 · kind: Represents the conversion of Class B Common Stock into Class A Common Stock.

F4 · ownership.nature: The shares are held by LAHWRAN-3 LLC, of which the Reporting Person is a member and a manager.

Read SEC document
March 02, 2023 Filed Mar 6, 2023 23:07 UTC
Gibson ChristopherDirector · Chief Executive Officer
SaleClass A Common Stock 18,500 $7.92 $146,501.50
Disclosure

SEC source: 0001209191-23-016450 · doc4.xml · nonDerivative · entry 2

Gibson Christopher · CIK 0001856369 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 940,927

F1 · kind: Transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F3 · price: This transaction was executed in multiple trades at prices ranging from $7.73 to $8.06. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

Read SEC document
March 02, 2023 Filed Mar 6, 2023 23:07 UTC
Gibson ChristopherDirector · Chief Executive Officer
ConversionClass A Common Stock 18,500 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-016450 · doc4.xml · nonDerivative · entry 1

Gibson Christopher · CIK 0001856369 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 956,427

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F2 · kind: Represents the conversion of Class B Common Stock into Class A Common Stock.

Read SEC document
March 02, 2023 Filed May 5, 2023 22:44 UTC
Gibson ChristopherDirector · Chief Executive Officer
ConversionClass B Common Stock · Derivative 3,000 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001209191-23-027830 · doc4.xml · derivative · entry 24

Gibson Christopher · CIK 0001856369 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,552,834

Underlying: Class A Common Stock · 3,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Represents the automatic conversion of Class B Common Stock into Class A Common Stock in connection with a bona-fide gift of shares by the Reporting Person

F2 · kind: This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 31, 2021

F14 · derivative.exercise_date: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.

F14 · derivative.expiration_date: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.

Read SEC document
March 02, 2023 Filed May 5, 2023 22:44 UTC
Gibson ChristopherDirector · Chief Executive Officer
GiftClass A Common Stock 3,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-027830 · doc4.xml · nonDerivative · entry 6

Gibson Christopher · CIK 0001856369 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 963,710

F2 · kind: This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 31, 2021

Read SEC document
March 02, 2023 Filed May 5, 2023 22:44 UTC
Gibson ChristopherDirector · Chief Executive Officer
ConversionClass A Common Stock 3,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-027830 · doc4.xml · nonDerivative · entry 5

Gibson Christopher · CIK 0001856369 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 966,710

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Represents the automatic conversion of Class B Common Stock into Class A Common Stock in connection with a bona-fide gift of shares by the Reporting Person

F2 · kind: This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 31, 2021

Read SEC document
March 01, 2023 Filed Mar 2, 2023 16:05 UTC PurchaseClass A Common Stock 48,867 $7.94 $388,082.17
Disclosure

SEC source: 0001387131-23-002722 · rxrx-form4_030123.xml · nonDerivative · entry 1

Mubadala Investment Co PJSC · CIK 0001704268 · 10% owner

Mamoura Diversified Global Holding PJSC · CIK 0001419351 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Explanation of Responses

Disclosed balance after: 12,919,105

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.84 to $7.97, inclusive. The reporting person undertakes to provide to Recursion Pharmaceuticals, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this Form 4.

F2 · ownership.nature: Consists of 12,919,105 shares held of record by Fifteenth Investment Company LLC. Fifteenth Investment Company LLC is a wholly owned subsidiary of Mamoura Diversified Global Holdings PJSC, which is wholly owned by Mubadala Investment Company PJSC, which is wholly owned by the Government of Abu Dhabi.

F4 · ownership.nature: Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any.

F5 · ownership.nature: Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests.

Read SEC document
February 28, 2023 Filed Mar 1, 2023 16:06 UTC PurchaseClass A Common Stock 815 $7.97 $6,495.55
Disclosure

SEC source: 0001387131-23-002678 · rxrx-form4_022823.xml · nonDerivative · entry 1

Mubadala Investment Co PJSC · CIK 0001704268 · 10% owner

Mamoura Diversified Global Holding PJSC · CIK 0001419351 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Explanation of Responses

Disclosed balance after: 12,870,238

F1 · ownership.nature: Consists of 12,870,238 shares held of record by Fifteenth Investment Company LLC. Fifteenth Investment Company LLC is a wholly owned subsidiary of Mamoura Diversified Global Holdings PJSC, which is wholly owned by Mubadala Investment Company PJSC, which is wholly owned by the Government of Abu Dhabi.

F3 · ownership.nature: Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any.

F4 · ownership.nature: Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests.

Read SEC document
February 27, 2023 Filed Feb 28, 2023 16:14 UTC PurchaseClass A Common Stock 52,500 $7.69 $403,725.00
Disclosure

SEC source: 0001387131-23-002560 · rxrx-form4_022723.xml · nonDerivative · entry 1

Mubadala Investment Co PJSC · CIK 0001704268 · 10% owner

Mamoura Diversified Global Holding PJSC · CIK 0001419351 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Explanation of Responses

Disclosed balance after: 12,869,423

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.57 to $7.81, inclusive. The reporting person undertakes to provide to Recursion Pharmaceuticals, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this Form 4.

F2 · ownership.nature: Consists of 12,869,423 shares held of record by Fifteenth Investment Company LLC. Fifteenth Investment Company LLC is wholly owned subsidiary of Mamoura Diversified Global Holdings PJSC, which is wholly owned by Mubadala Investment Company PJSC, which is wholly owned by the Government of Abu Dhabi.

F4 · ownership.nature: Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any.

F5 · ownership.nature: Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests.

Read SEC document
February 24, 2023 Filed Feb 27, 2023 16:06 UTC PurchaseClass A Common Stock 109,118 $7.64 $833,552.40
Disclosure

SEC source: 0001839882-23-004972 · rxrx-form4_022423.xml · nonDerivative · entry 1

Mubadala Investment Co PJSC · CIK 0001704268 · 10% owner

Mamoura Diversified Global Holding PJSC · CIK 0001419351 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Explanation of Responses

Disclosed balance after: 12,816,923

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.56 to $7.86, inclusive. The reporting person undertakes to provide to Recursion Pharmaceuticals, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4.

F2 · ownership.nature: Consists of 12,816,923 shares held of record by Fifteenth Investment Company LLC. Fifteenth Investment Company LLC is wholly owned subsidiary of Mamoura Diversified Global Holdings PJSC, which is wholly owned by Mubadala Investment Company PJSC, which is wholly owned by the Government of Abu Dhabi.

F4 · ownership.nature: Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any.

F5 · ownership.nature: Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests.

Read SEC document
February 23, 2023 Filed Feb 24, 2023 16:08 UTC PurchaseClass A Common Stock 51,864 $7.79 $403,792.36
Disclosure

SEC source: 0001387131-23-002375 · rxrx-form4_022323.xml · nonDerivative · entry 1

Mubadala Investment Co PJSC · CIK 0001704268 · 10% owner

Mamoura Diversified Global Holding PJSC · CIK 0001419351 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Explanation of Responses

Disclosed balance after: 12,707,805

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.72 to $7.97, inclusive. The reporting person undertakes to provide to Recursion Pharmaceuticals, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4.

F2 · ownership.nature: Consists of 12,707,805 shares held of record by Fifteenth Investment Company LLC. Fifteenth Investment Company LLC is wholly owned subsidiary of Mamoura Diversified Global Holdings PJSC, which is wholly owned by Mubadala Investment Company PJSC, which is wholly owned by the Government of Abu Dhabi.

F4 · ownership.nature: Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any.

F5 · ownership.nature: Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests.

Read SEC document
February 23, 2023 Filed Feb 27, 2023 22:46 UTC
Marriott TinaPresident and COO
Exercise / conversionStock Option (Right to Buy) · Derivative 8,000 $0.00 Strike: $1.06 $0.00
Disclosure

SEC source: 0001209191-23-013329 · doc4.xml · derivative · entry 3

Larson Tina Marriott · CIK 0001856414 · President and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 546,000

Underlying: Class A Common Stock · 8,000 shares

Expires 2028-07-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person.

F3 · derivative.exercise_date: Twenty-Five percent (25%) of the shares subject to the award (the stock option grant was for a total of 765,000 shares prior to exercise) shall vest one year after July 16, 2018, or the Annual Vesting Commencement Date, and one-forty-eighth (1/48th) of the shares subject to the award shall vest each month thereafter on the same day of the month as the Annual Vesting Commencement Date.

Read SEC document
February 23, 2023 Filed Feb 27, 2023 22:46 UTC
Marriott TinaPresident and COO
SaleClass A Common Stock 8,000 $7.82 $62,540.00
Disclosure

SEC source: 0001209191-23-013329 · doc4.xml · nonDerivative · entry 2

Larson Tina Marriott · CIK 0001856414 · President and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 427,844

F1 · kind: Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person.

F2 · price: The sales price reported herein is a weighted average price. These shares were sold in multiple lots at prices ranging from $7.74 to $8.08 per share. Full sale price information for each lot is available to the Issuer's stockholders and the staff of the U.S. Securities and Exchange Commission upon their written request.

Read SEC document
February 23, 2023 Filed Feb 27, 2023 22:46 UTC
Marriott TinaPresident and COO
Exercise / conversionClass A Common Stock 8,000 $1.06 $8,480.00
Disclosure

SEC source: 0001209191-23-013329 · doc4.xml · nonDerivative · entry 1

Larson Tina Marriott · CIK 0001856414 · President and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 435,844

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person.

Read SEC document
February 22, 2023 Filed Feb 23, 2023 16:26 UTC PurchaseClass A Common Stock 50,941 $7.83 $399,015.76
Disclosure

SEC source: 0001387131-23-002324 · rxrx-form4_022323.xml · nonDerivative · entry 1

Mubadala Investment Co PJSC · CIK 0001704268 · 10% owner

Mamoura Diversified Global Holding PJSC · CIK 0001419351 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Explanation of Responses

Disclosed balance after: 12,655,941

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.69 to $7.94, inclusive. The reporting person undertakes to provide to Recursion Pharmaceuticals, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4

F2 · ownership.nature: Consists of 12,655,941 shares held of record by Fifteenth Investment Company LLC. Fifteenth Investment Company LLC is wholly owned subsidiary of Mamoura Diversified Global Holdings PJSC, which is wholly owned by Mubadala Investment Company PJSC, which is wholly owned by the Government of Abu Dhabi.

F4 · ownership.nature: Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any.

F5 · ownership.nature: Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests.

Read SEC document
February 21, 2023 Filed Feb 22, 2023 16:07 UTC PurchaseClass A Common Stock 94,418 $7.74 $731,125.78
Disclosure

SEC source: 0001387131-23-002285 · rxrx-form4_022123.xml · nonDerivative · entry 1

Mubadala Investment Co PJSC · CIK 0001704268 · 10% owner

Mamoura Diversified Global Holding PJSC · CIK 0001419351 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Explanation of Responses

Disclosed balance after: 12,605,000

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.65 to $7.97, inclusive. The reporting person undertakes to provide to Recursion Pharmaceuticals, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4

F2 · ownership.nature: Consists of 12,605,000 shares held of record by Fifteenth Investment Company LLC. Fifteenth Investment Company LLC is wholly owned subsidiary of Mamoura Diversified Global Holdings PJSC, which is wholly owned by Mubadala Investment Company PJSC, which is wholly owned by the Government of Abu Dhabi.

F4 · ownership.nature: Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any.

F5 · ownership.nature: Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests.

Read SEC document
February 21, 2023 Filed Feb 23, 2023 22:48 UTC SaleClass A Common Stock 8,885 $7.73 $68,707.71
Disclosure

SEC source: 0001209191-23-012321 · doc4.xml · nonDerivative · entry 1

Borgeson Blake · CIK 0001856094 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,594,057

F1 · kind: Sales are pursuant to a 10b5-1 trading plan established by the Reporting Person.

F2 · price: The sales price reported herein is a weighted average price. These shares were sold in multiple lots at prices ranging from $7.66 to $7.97 per share. Full sale price information for each lot is available to the Issuer's stockholders and the staff of the U.S. Securities and Exchange Commission upon their written request.

Read SEC document
February 17, 2023 Filed Feb 21, 2023 16:07 UTC PurchaseClass A Common Stock 63,382 $7.71 $488,985.79
Disclosure

SEC source: 0001387131-23-002254 · rxrx-form4_021723.xml · nonDerivative · entry 1

Mubadala Investment Co PJSC · CIK 0001704268 · 10% owner

Mamoura Diversified Global Holding PJSC · CIK 0001419351 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Explanation of Responses

Disclosed balance after: 12,510,582

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.58 to $7.97, inclusive. The reporting person undertakes to provide to Recursion Pharmaceuticals, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4.

F2 · ownership.nature: Consists of 12,510,582 shares held of record by Fifteenth Investment Company LLC. Fifteenth Investment Company LLC is wholly owned subsidiary of Mamoura Diversified Global Holdings PJSC, which is wholly owned by Mubadala Investment Company PJSC, which is wholly owned by the Government of Abu Dhabi.

F4 · ownership.nature: Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any.

F5 · ownership.nature: Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests.

Read SEC document
February 16, 2023 Filed Feb 17, 2023 17:27 UTC PurchaseClass A Common Stock 42,682 $7.90 $337,042.68
Disclosure

SEC source: 0001387131-23-002226 · rxrx-form4_021623.xml · nonDerivative · entry 1

Mubadala Investment Co PJSC · CIK 0001704268 · 10% owner

Mamoura Diversified Global Holding PJSC · CIK 0001419351 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Explanation of Responses

Disclosed balance after: 12,447,200

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.84 to $7.97, inclusive. The reporting person undertakes to provide to Recursion Pharmaceuticals, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4.

F2 · ownership.nature: Consists of 12,447,200 shares held of record by Fifteenth Investment Company LLC. Fifteenth Investment Company LLC is a wholly owned subsidiary of Mamoura Diversified Global Holdings PJSC, which is wholly owned by Mubadala Investment Company PJSC, which is wholly owned by the Government of Abu Dhabi.

F4 · ownership.nature: Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any.

F5 · ownership.nature: Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.